Re:Oxford University breakthrough on global COVID-19 vaccine
by beagle3 on Monday November 23, 2020 @10:52AM
(#25188022)
You sum the expenditure and divide by number of successes, with some accounting for the delay. It is actually much easier than trying to figure out the cost of a specific drug, because research is sometimes shared.
How do you account for the failed attempts?
As yomly alludes to, pharma startups exist because they don't own the risk - their investors bought it when they were funded. Big pharma does own the risk.